Indications for intervention in asymptomatic children with chronic mitral regurgitation

Joyce T Johnson1, Aaron W Eckhauser, Nelangi M Pinto

  • 1The Division of Cardiology, Primary Children's Hospital and the University of Utah, 100 N. Mario Capecchi Dr., Salt Lake City, UT, 84113, USA, jtawfik@gmail.com.

Pediatric Cardiology
|October 12, 2014
PubMed

Insights

Surgery for asymptomatic children with chronic mitral regurgitation (MR) is recommended before left ventricular end-systolic Z score (LVESZ) exceeds five and shortening fraction (SF) falls below 33%. Patients with SF > 33% may be monitored with echocardiography.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Echocardiography

Background:

  • Indications for mitral valve surgery in asymptomatic children with chronic mitral regurgitation (MR) are not well-defined.
  • Adult guidelines for MR surgery do not directly translate to pediatric populations.
  • Predicting postoperative left ventricular (LV) dysfunction in children requires specific pediatric data.

Purpose of the Study:

  • To identify predictors of late left ventricular (LV) dysfunction after mitral valve surgery in asymptomatic children with chronic mitral regurgitation (MR).
  • To establish echocardiographic criteria for surgical intervention in pediatric MR.
  • To guide timing of surgery to optimize LV function preservation.

Main Methods:

  • Retrospective review of a surgical database for children undergoing mitral valve surgery for chronic MR between 2000 and 2012.
  • Exclusion of patients with preoperative symptoms, acute MR, cardiomyopathy, or other cardiac defects.
  • Analysis of preoperative and follow-up clinical and echocardiographic data, defining LV dysfunction as ejection fraction (EF) ≤55% or shortening fraction (SF) ≤28%.

Main Results:

  • Nine out of 25 eligible children (36%) developed late LV dysfunction.
  • Lower preoperative shortening fraction (SF) (OR 0.6) and higher LV end-systolic Z score (LVESZ) (OR 1.7) were significantly associated with late LV dysfunction.
  • A combination of LVESZ ≥ 5 and SF ≤ 33% predicted late LV dysfunction with 89% sensitivity and 88% specificity.

Conclusions:

  • Asymptomatic children with chronic MR should be considered for surgery before LVESZ exceeds 5 and SF drops below 33% to prevent LV dysfunction.
  • Preoperative SF > 33% was associated with a low incidence of late LV dysfunction, suggesting a potential threshold for monitoring.
  • Serial echocardiographic monitoring may be appropriate for children with SF > 33%.

Related Concept Videos

Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
901
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
663
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
501
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
589
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
540